GBF Stock Analysis: Bilfinger SE | XETRA
Engineering & Construction | XETRA, Germany | Market Cap: 2.093m EUR | 12M Return: -44.5% | DE0005909006 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.6M
EPS Trend: 94.8%
Qual. Beats: 0
Rev. Trend: 98.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bilfinger SE is a German-headquartered industrial services provider operating primarily in Europe, North America, and the Middle East. The company serves process industry clients across three segments: Engineering & Maintenance Europe, Engineering & Maintenance International, and Technologies. Its service portfolio spans engineering, project execution, maintenance, turnarounds, inspection, insulation, scaffolding, corrosion protection, mechanical/electrical/instrumentation work, digital services, and nuclear decommissioning. Bilfinger also supports emerging energy areas including hydrogen, carbon capture and storage, wind power, biogas, and battery production, alongside traditional end markets such as energy, chemicals and petrochemicals, oil and gas, and pharma and biopharma. Founded in 1880, the company is listed on XETRA under the ticker GBF and is classified within the GICS Construction & Engineering sub-industry.
As an industrial services contractor, Bilfingers business model is largely project- and maintenance-driven, generating revenue from outsourced engineering and plant servicing for asset-heavy operators. Companies in this sub-industry typically benefit from long-term service agreements and recurring maintenance work, while exposure to energy-transition end markets positions the firm to capture demand from clients decarbonizing their process infrastructure.
- Nuclear decommissioning backlog expands across European power plants
- Energy transition services demand lifts Engineering & Maintenance Europe margins
- Middle East order intake drives International segment revenue growth
| Net Income: 187.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -2.25 > 1.0 |
| NWC/Revenue: 6.30% < 20% (prev 6.67%; Δ -0.37% < -1%) |
| CFO/TA 0.08 > 3% & CFO 275.0m > Net Income 187.6m |
| Net Debt (187.0m) to EBITDA (421.6m): 0.44 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.9m) vs 12m ago -1.61% < -2% |
| Gross Margin: 11.08% > 18% (prev 11.25%; Δ -0.17% > 0.5%) |
| Asset Turnover: 159.6% > 50% (prev 152.2%; Δ 7.46% > 0%) |
| Interest Coverage Ratio: 8.87 > 6 (EBIT TTM 278.4m / Interest Expense TTM 31.4m) |
| A: 0.10 (Total Current Assets 2.04b - Total Current Liabilities 1.69b) / Total Assets 3.52b |
| B: 0.14 (Retained Earnings 496.2m / Total Assets 3.52b) |
| C: 0.08 (EBIT TTM 278.4m / Avg Total Assets 3.49b) |
| D: 0.62 (Book Value of Equity 1.34b / Total Liabilities 2.16b) |
| Altman-Z'' = 2.30 = BBB |
| DSRI: 0.10 (Receivables 27.4m/1.39b, Revenue 5.57b/5.27b) |
| GMI: 1.02 (GM 11.25% / 11.08%) |
| AQI: 1.04 (AQ_t 0.28 / AQ_t-1 0.27) |
| SGI: 1.06 (Revenue 5.57b / 5.27b) |
| TATA: -0.02 (NI 187.6m - CFO 275.0m) / TA 3.52b) |
| Beneish M = -3.69 (Cap -4..+1) = AAA |
As of October 09, 2026, the stock is trading at EUR 53.95 with a total of 196,312 shares traded. Over the past week, the price has changed by -3.66%, over one month by -33.84%, over three months by -34.65% and over the past year by -44.46%.
Current recommended Stop Loss: 51.00 (which is 5.5% or 1.2 ATR below the current price).
Bilfinger SE has no consensus analysts rating.
P/E Trailing = 11.2849
P/E Forward = 10.4384
P/S = 0.3757
P/B = 1.5769
P/EG = 3.6182
Revenue TTM = 5.57b EUR
EBIT TTM = 278.4m EUR
EBITDA TTM = 421.6m EUR
Long Term Debt = 25.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 61.3m EUR (from shortTermDebt, last quarter)
Debt = 419.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 197.1m
Net Debt = 187.0m EUR (calculated: Debt 419.6m - CCE 232.6m)
Enterprise Value = 2.28b EUR (2.09b + Debt 419.6m - CCE 232.6m)
Interest Coverage Ratio = 8.87 (Ebit TTM 278.4m / Interest Expense TTM 31.4m)
EV/FCF = 11.09x (Enterprise Value 2.28b / FCF TTM 205.6m)
FCF Yield = 9.02% (FCF TTM 205.6m / Enterprise Value 2.28b)
FCF Margin = 3.69% (FCF TTM 205.6m / Revenue TTM 5.57b)
Net Margin = 3.37% (Net Income TTM 187.6m / Revenue TTM 5.57b)
Gross Margin = 11.08% ((Revenue TTM 5.57b - Cost of Revenue TTM 4.95b) / Revenue TTM)
Gross Margin QoQ = 10.79% (prev 10.80%)
Tobins Q-Ratio = 0.65 (Enterprise Value 2.28b / Total Assets 3.52b)
Interest Expense / Debt = 7.48% (Interest Expense 31.4m / Debt 419.6m)
Taxrate = 25.54% (66.1m / 258.8m)
NOPAT = 207.3m (EBIT 278.4m * (1 - 25.54%))
Current Ratio = 1.21 (Total Current Assets 2.04b / Total Current Liabilities 1.69b)
Debt / Equity = 0.31 (Debt 419.6m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 0.44 (Net Debt 187.0m / EBITDA 421.6m)
Debt / FCF = 0.91 (Net Debt 187.0m / FCF TTM 205.6m)
Total Stockholder Equity = 1.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.38% (Net Income 187.6m / Total Assets 3.52b)
RoE = 14.00% (Net Income TTM 187.6m / Total Stockholder Equity 1.34b)
RoCE = 20.38% (EBIT 278.4m / Capital Employed (Equity 1.34b + L.T.Debt 25.4m))
RoIC = 12.54% (NOPAT 207.3m / Invested Capital 1.65b)
WACC = 6.41% (E(2.09b)/V(2.51b) * Re(6.58%) + D(419.6m)/V(2.51b) * Rd(7.48%) * (1-Tc(0.26)))
Discount Rate = 6.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.29 | Cagr: -0.93%
[DCF] Terminal Value 73.10% ; FCFF base≈235.4m ; Y1≈206.4m ; Y5≈166.8m
[DCF] Fair Price = 67.40 (EV 2.68b - Net Debt 187.0m = Equity 2.49b / Shares 36.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 94.75 | EPS CAGR: 26.39% | SUE: -0.32 | # QB: 0
Revenue Correlation: 98.20 | Revenue CAGR: 9.78% | SUE: 0.10 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.27 | Chg30d=-22.75% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=4.97 | Chg30d=-16.78% | Revisions=+0% | GrowthEPS=-4.2% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=6.00 | Chg30d=-12.80% | Revisions=-25% | GrowthEPS=+20.8% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -40% (up=0, down=2)